Awards as PI
| Funding | ||
|---|---|---|
| Early Translational I | Using patient-specific iPSC derived dopaminergic neurons to overcome a major bottleneck in Parkinson's disease research and drug discovery | $3,701,766 |
| Tools and Technologies II | Editing of Parkinson’s disease mutation in patient-derived iPSCs by zinc-finger nucleases | $1,327,983 |
Total: $5,029,749.00 |
